Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mayes

Showing results (271-280 of 382) with videos related to

Pageof 39
Sort By:
The Journal of Rheumatology|February 1, 2026
Comparing Novel and Legacy Health Assessment Questionnaire Scoring Methods: A Scleroderma Patient-centered Intervention Network Cohort StudyYining Lu, Daphna Harel, Klint Kanopka, et al.
Annals of the Rheumatic Diseases|January 18, 2023
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantationBurcu Ayoglu, Michele Donato, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2023
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Christopher P Denton, Daniel E Furst, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
The Journal of Rheumatology|October 17, 2015
Autoantibodies to Dense Fine Speckles in Pediatric Diseases and ControlsHeinrike Schmeling, Michael Mahler, Deborah M Levy, et al.
Rheumatology (Oxford, England)|June 7, 2019
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
The Journal of Investigative Dermatology|December 17, 2021
Genetic Associations of Non-Major Histocompatibility Complex Susceptibility Loci with Systemic Sclerosis in a Han Chinese PopulationWeilin Pu, Rui Zhang, Yanyun Ma, et al.
Pageof 39

Showing results (271-280 of 382) with videos related to

Sort By:
Pageof 39
The Journal of Rheumatology|February 1, 2026
Comparing Novel and Legacy Health Assessment Questionnaire Scoring Methods: A Scleroderma Patient-centered Intervention Network Cohort StudyYining Lu, Daphna Harel, Klint Kanopka, et al.
Annals of the Rheumatic Diseases|January 18, 2023
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantationBurcu Ayoglu, Michele Donato, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2023
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Christopher P Denton, Daniel E Furst, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
The Journal of Rheumatology|October 17, 2015
Autoantibodies to Dense Fine Speckles in Pediatric Diseases and ControlsHeinrike Schmeling, Michael Mahler, Deborah M Levy, et al.
Rheumatology (Oxford, England)|June 7, 2019
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
The Journal of Investigative Dermatology|December 17, 2021
Genetic Associations of Non-Major Histocompatibility Complex Susceptibility Loci with Systemic Sclerosis in a Han Chinese PopulationWeilin Pu, Rui Zhang, Yanyun Ma, et al.
Pageof 39